カテゴリ： MarketLine, アメリカ, 企業調査

Weyerhaeuser Company：企業の戦略・SWOT・財務情報

◆英語タイトル：Weyerhaeuser Company - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3642
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：44
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：農業
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥24,150見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥48,300見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥72,450見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Weyerhaeuser Company – Strategy, SWOT and Corporate Finance Report
Summary

Weyerhaeuser Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Weyerhaeuser Company (Weyerhaeuser or ‘the company’) is a forest products company that grows and harvests trees, and manufactures a range of forest products essential for everyday usage. Its major products include structural lumber, engineered solid section, engineered I-joists, oriented strand board, softwood plywood and hardwood lumber which in turn cater to the needs of new residential building, industrial, light commercial, multi-family, and repair remodel markets. Weyerhaeuser is headquartered in Seattle, Washington, the US.

Scope

- Detailed information on Weyerhaeuser Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Weyerhaeuser Company in the form of a SWOT analysis
- An in-depth view of the business model of Weyerhaeuser Company including a breakdown and examination of key business segments
- Intelligence on Weyerhaeuser Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Weyerhaeuser Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Weyerhaeuser Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Weyerhaeuser Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Weyerhaeuser Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Weyerhaeuser Company: Company Overview 8
Weyerhaeuser Company: Overview and Key Facts 8
Weyerhaeuser Company: Overview 8
Weyerhaeuser Company: Key Facts 8
Weyerhaeuser Company: Key Employees 9
Weyerhaeuser Company: Key Employee Biographies 10
Weyerhaeuser Company: Major Products and Services 16
Weyerhaeuser Company: Company History 17
Weyerhaeuser Company: Locations and Subsidiaries 21
Weyerhaeuser Company: Key Competitors 22
Weyerhaeuser Company: Company Analysis 23
Weyerhaeuser Company: Business Description 23
Weyerhaeuser Company: SWOT Analysis 25
Weyerhaeuser Company: SWOT Overview 25
Weyerhaeuser Company: Strengths 25
Weyerhaeuser Company: Weaknesses 26
Weyerhaeuser Company: Opportunities 27
Weyerhaeuser Company: Threats 28
Weyerhaeuser Company: Corporate Financial Deals Activity 30
Weyerhaeuser Company: Financial Deals Overview 30
Weyerhaeuser Company: Targets and Partners 31
Weyerhaeuser Company: Top Deals 2014 – 2018YTD* 32
Weyerhaeuser Company: Advisors 33
Weyerhaeuser Company: Top Financial Advisors 33
Weyerhaeuser Company: Mergers and Acquisitions 34
Weyerhaeuser Company: Divestments 35
Weyerhaeuser Company: Recent Developments 36
Weyerhaeuser Company: News and Events Summary 36
Weyerhaeuser Company: Corporate Governance 38
Weyerhaeuser Company: Financial Performance 39
Weyerhaeuser Company: Regulatory and Legal Events 40
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: Weyerhaeuser Company: Key Facts
Table 2: Weyerhaeuser Company: Key Employees
Table 3: Weyerhaeuser Company: Locations and Subsidiaries
Table 4: Weyerhaeuser Company: Key Competitors
Table 5: Weyerhaeuser Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Weyerhaeuser Company: M&A Average Deal Size - Value (US$m)
Table 7: Weyerhaeuser Company: Targets and Partners
Table 8: Weyerhaeuser Company: Top Deals 2014 - 2018YTD*
Table 9: Weyerhaeuser Company: Financial Advisor Ranking by Value (US$m)
Table 10: Weyerhaeuser Company: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Weyerhaeuser Company: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Weyerhaeuser Company: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: Weyerhaeuser Company: Divestments by Geography (2014 - YTD*2018)
Table 14: Weyerhaeuser Company: News and Events Summary
Table 15: Weyerhaeuser Company: Corporate Governance
Table 16: Weyerhaeuser Company: Financial Performance
Table 17: Weyerhaeuser Company: Regulatory and Legal Events

List of Figures
Figure 1: Weyerhaeuser Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Weyerhaeuser Company: M&A Average Deal Size - Value (US$m)
Figure 3: Weyerhaeuser Company: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Weyerhaeuser Company: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Weyerhaeuser Company: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Weyerhaeuser Company: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Weyerhaeuser Company：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Keryx Biopharmaceuticals Inc (KERX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Keryx Biopharmaceuticals Inc (Keryx) develops and commercializes new therapies for the treatment of renal disease. The company’s lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based phosphate binder, which helps lower the amount of phosphate in human blood. Au …
  • Seair Inc：企業の戦略的SWOT分析
    Seair Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Gannett Co., Inc.：戦略・SWOT・企業財務分析
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tribune Media Company：企業の戦略・SWOT・財務分析
    Tribune Media Company - Strategy, SWOT and Corporate Finance Report Summary Tribune Media Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Diffusion Pharmaceuticals Inc (DFFN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Jiangsu Jiuding New Material Co Ltd (002201)：企業の財務・戦略的SWOT分析
    Jiangsu Jiuding New Material Co Ltd (002201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Active Implants LLC：医療機器：M&Aディール及び事業提携情報
    Summary Active Implants LLC (Active Implants), formerly Active Implants Corp is a medical equipment provider that develops orthopedic equipment. The company develops and commercializes polymer orthopedic implant solutions which include tribofit hip system, tribofit instrumentation equipment, NuSurfa …
  • Biogen Inc (BIIB)：医療機器：M&Aディール及び事業提携情報
    Summary Biogen Inc (Biogen) is a global biopharmaceutical company that discovers, develops and delivers drugs for the treatment of neurological and neurodegenerative diseases worldwide. The company’s marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fu …
  • Fortis Inc (FTS)：企業の財務・戦略的SWOT分析
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …
  • Corizon Health Inc：企業の戦略的SWOT分析
    Corizon Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Booz Allen Hamilton Holding Corporation：企業の戦略・SWOT・財務情報
    Booz Allen Hamilton Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary Booz Allen Hamilton Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • HOB Biotech Group Suzhou Co Ltd：医療機器：M&Aディール及び事業提携情報
    Summary HOB Biotech Group Suzhou Co Ltd (HOB Biotech) is a manufacturer of allergy and autoimmune in vitro diagnostics. It owns and operates bioclia, bioline, and biolisa. The company’s bioclia is engaged in cutting-edge nanoparticle and chemiluminescent technology, and chemiluminescent immuno assay …
  • Shinva Medical Instrument Co Ltd (600587)：医療機器：M&Aディール及び事業提携情報
    Summary Shinva Medical Instrument Co., Ltd. (Shinva Medical) manufactures and markets medical instruments and environmental protection equipment for various healthcare markets. The company’s product portfolio includes sterilizers, radiotherapy equipment, digital diagnosis equipment, surgical instrum …
  • Mari Petroleum Co Ltd (MARI)：企業の財務・戦略的SWOT分析
    Mari Petroleum Co Ltd (MARI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Electricity Authority of Cyprus：企業の戦略的SWOT分析
    Electricity Authority of Cyprus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Red Electrica de Espana SA (REE)-エネルギー分野：企業M&A・提携分析
    Summary Red Electrica de Espana, S.A. (REE), a subsidiary of Red Electrica Corporacion S A. is a power transmission company. The company is involved in electricity transmission and other related operations through its transmission network. It manages the high-voltage transmission grid and is also re …
  • Hera SpA (HER)：企業の財務・戦略的SWOT分析
    Hera SpA (HER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Croma-Pharma GmbH：医療機器：M&Aディール及び事業提携情報
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company that offers development and commercialization of drugs in the field of aesthetic dermatology. The company’s products include princess skincare, princess injectables, and princess lift products. Its princess skincare products compri …
  • ImpediMed Ltd (IPD)：製品パイプライン分析
    Summary ImpediMed Ltd (ImpediMed) is a manufacturer of bioimpedance devices with a focus on medical applications in the fluid status domain. It designs, manufactures and sells bioimpedance spectroscopy (BIS) devices for assessing lymphoedema and body composition. The major products of the company in …
  • Exact Sciences Corp (EXAS)：医療機器：M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆